| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 01/30/2003 | CA2443524A1 Methods of profiling gene expression, protein or metabolite levels |
| 01/30/2003 | CA2395992A1 Method for the screening of compounds that inhibit the interaction between a proline-rich peptide and a sh3 domain comprising peptide |
| 01/29/2003 | WO2002010350A1 Method of proliferating natural killer cells |
| 01/29/2003 | EP1279963A1 Protein-target screening method using near-infrared fluorescent dyes |
| 01/29/2003 | EP1279744A2 Identification and use of molecules implicated in pain |
| 01/29/2003 | EP1279741A1 Method of production of deletion mutants |
| 01/29/2003 | EP1279740A1 Recombinant vector derived from adeno-associated virus for gene therapy |
| 01/29/2003 | EP1279739A1 Recombinant vectors derived from adeno-associated virus expressing TAM67 for gene therapy |
| 01/29/2003 | EP1279738A1 Gene delivery vectors with cell type specificity for mesenchymal stem cells |
| 01/29/2003 | EP1279737A1 Transformation method for obtaining marker-free plants |
| 01/29/2003 | EP1279736A1 Methods of RNA and protein synthesis |
| 01/29/2003 | EP1279735A1 Malaria plasmodium antigen polypeptide se36, method of purifying the same and vaccine and diagnostic with the use of the thus obtained antigen |
| 01/29/2003 | EP1279734A1 Molecular methods of hybrid seed production |
| 01/29/2003 | EP1279733A1 Nucleic acids and polypeptides involved in the predisposition to infection to human papilloma virus, to epidermodysplasia verruciformis and/or to psoriasis |
| 01/29/2003 | EP1279732A2 Method for the isolation of large diversities of molecules specific for a target molecule from phagemid gene libraries |
| 01/29/2003 | EP1279731A1 Process for the development of binding mini-proteins |
| 01/29/2003 | EP1279730A1 Methods for screening for proteins comprising a signal sequence |
| 01/29/2003 | EP1279678A1 Gag antigen and other orf fragments of lav virus. Use for the detection of lav infection and in immunogenic compositions |
| 01/29/2003 | EP1279434A2 Hybridization substrate, method of manufacturing same, and method of use for same |
| 01/29/2003 | EP1279412A2 Pressure-mediated intracellular delivery of molecules of microparticles |
| 01/29/2003 | EP1279404A1 Use of HIV-1 tat, fragments or derivatives thereof, to target or to activate antigen-presenting cells, to deliver cargo molecules for vaccination or to treat other diseases |
| 01/29/2003 | EP1279332A2 Transgenic non-human mammal |
| 01/29/2003 | EP1279120A2 System for functional gene discovery in plants |
| 01/29/2003 | EP1279039A1 Diagnostic assay and method of treatment involving macrophage inhibitory cytokine -1 (mic-1) |
| 01/29/2003 | EP1279038A2 Method of identifying agents that alter the activity of the promoter sequence for crf receptor 2-alpha |
| 01/29/2003 | EP1278893A2 Diagnosis of diseases associated with dna replication |
| 01/29/2003 | EP1278890A1 A method of detecting neoplastic or non-neoplastic cells |
| 01/29/2003 | EP1278889A2 Hybridisation beacon and method of rapid sequence detection and discrimination |
| 01/29/2003 | EP1278886A2 Sigma binding region of rna polymerase and uses thereof |
| 01/29/2003 | EP1278884A1 Immunoglobulin binding protein arrays in plant cells |
| 01/29/2003 | EP1278882A1 Overproduction hosts for biosynthesis of polyketides |
| 01/29/2003 | EP1278881A1 Hybrid glycosylated products and their production and use |
| 01/29/2003 | EP1278878A2 Codon optimisation for expression in retrovirus packaging cells |
| 01/29/2003 | EP1278877A1 Use of 3'-utr's from cysteine proteinase genes cpb2 and cpb2.8 of leishmania for directing stage-specific expression |
| 01/29/2003 | EP1278876A2 STABLE i ZYMOMONAS MOBILIS /i XYLOSE AND ARABINOSE FERMENTING STRAINS |
| 01/29/2003 | EP1278875A1 Crystallography methods |
| 01/29/2003 | EP1278874A2 Hybrid protein and vector encoding the same for inhibition of angiogenesis |
| 01/29/2003 | EP1278873A1 Fermentative production of ethanol by heterologous expression of a pyruvate decarboxylase gene in bacillus sp |
| 01/29/2003 | EP1278872A1 Novel plant glucosidase i and use thereof for producing recombinant proteins with modified glycosylation |
| 01/29/2003 | EP1278871A2 Human phospholipase c delta 5 |
| 01/29/2003 | EP1278870A1 Splice variant of camp phosphodiesterase type 7 (pde7a3) |
| 01/29/2003 | EP1278869A2 Proteases |
| 01/29/2003 | EP1278868A2 Novel mutated form of arginine deiminase |
| 01/29/2003 | EP1278867A2 Hcv ns2/3 fragments and uses thereof |
| 01/29/2003 | EP1278866A2 Serine-threonine kinase |
| 01/29/2003 | EP1278865A1 Nucleotide sequences which code for the pgsa2 gene |
| 01/29/2003 | EP1278864A2 Serine-threonine kinase-3 |
| 01/29/2003 | EP1278863A2 Human serine-threonine kinase-4 |
| 01/29/2003 | EP1278862A2 Nucleotide sequences coding for the cls gene |
| 01/29/2003 | EP1278861A2 Nucleotide sequences coding for the cdsa gene |
| 01/29/2003 | EP1278860A2 Nucleotide sequences which code for the cma gene |
| 01/29/2003 | EP1278859A2 Human protein kinases and protein kinase-like enzymes |
| 01/29/2003 | EP1278858A2 46743 and 27417, novel human acyltransferase family members and uses therefor |
| 01/29/2003 | EP1278857A1 Nucleotide sequences which code for the fadd15 gene |
| 01/29/2003 | EP1278856A2 Immunogenic pneumococcal protein and vaccine compositions thereof |
| 01/29/2003 | EP1278855A2 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 01/29/2003 | EP1278854A2 Compositions and methods for the therapy and diagnosis of acne vulgaris |
| 01/29/2003 | EP1278853A2 Listeria monocytogenes genome, polypeptides and uses |
| 01/29/2003 | EP1278852A2 Zsig33-like peptides |
| 01/29/2003 | EP1278851A1 Humanised antibodies to the epidermal growth factor receptor |
| 01/29/2003 | EP1278850A1 Edg8 receptor, its preparation and use |
| 01/29/2003 | EP1278849A2 Thrombopoietin receptor modulating peptide |
| 01/29/2003 | EP1278848A1 New ras guanine-nucleotide-exchange factor 1 (nrg1) |
| 01/29/2003 | EP1278847A1 New gtpase-activating protein 1 |
| 01/29/2003 | EP1278846A2 Cytoskeleton-associated proteins |
| 01/29/2003 | EP1278845A2 Cellular regulators of infectious agents and methods of use |
| 01/29/2003 | EP1278844A2 G protein-coupled receptors |
| 01/29/2003 | EP1278843A2 Rna metabolism proteins |
| 01/29/2003 | EP1278842A2 Dna encoding the prost 03 polypeptide |
| 01/29/2003 | EP1278840A2 Isolated human g-protein coupled receptors of the mas proto-oncogene subfamily, nucleic acid molecules encoding human gpcr proteins, and uses thereof |
| 01/29/2003 | EP1278839A2 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof |
| 01/29/2003 | EP1278838A2 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof |
| 01/29/2003 | EP1278837A2 Internal de novo initiation sites of the hcv ns5b polymerase and use thereof |
| 01/29/2003 | EP1278835A2 Method for producing dna encoding polypeptides that are composed of several sections, and for producing polypeptides by expressing the dna thus obtained |
| 01/29/2003 | EP1278834A2 Polyfunctional support material for complex nucleic acid analysis |
| 01/29/2003 | EP1278833A2 Method for producing genomic libraries and genomic libraries produced therewith |
| 01/29/2003 | EP1278832A1 Methods and compositions for effecting homologous recombination |
| 01/29/2003 | EP1278831A2 Method for indirectly extracting non-cultivable dna organisms and dna obtainable by said method |
| 01/29/2003 | EP1278829A2 Surfactant protein d for the prevention and diagnosis of pulmonary emphysema |
| 01/29/2003 | EP1278827A2 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof |
| 01/29/2003 | EP1278826A1 Novel proteins |
| 01/29/2003 | EP1278824A2 Clearance of ras-mediated neoplastic cells from mixed cellular compositions using reovirus |
| 01/29/2003 | EP1278823A2 Clearance of neoplastic cells from mixed cellular compositions using viruses |
| 01/29/2003 | EP1278803A2 Sulfonated 8,9]benzophenoxazine dyes and the use of their labelled conjugates |
| 01/29/2003 | EP1278778A2 Modified peptides, comprising an fc domain, as therapeutic agents |
| 01/29/2003 | EP1278777A2 G protein coupled receptor (gpcr) agonists and antagonists and methods of activating and inhibiting gpcr using the same |
| 01/29/2003 | EP1278776A2 Isolated human transporter proteins, nucleic acids and uses thereof |
| 01/29/2003 | EP1278775A2 Isolated human g-protein coupled receptors that are members of the aminergic subfamily, nucleic acid molecules encoding human gpcr proteins, and uses thereof |
| 01/29/2003 | EP1278774A2 Human g-protein coupled receptors |
| 01/29/2003 | EP1278773A2 Selectable cell surface marker genes |
| 01/29/2003 | EP1278772A2 Glucagon antagonists |
| 01/29/2003 | EP1278770A1 Human wingless-like gene |
| 01/29/2003 | EP1278767A1 Albumin fusion proteins |
| 01/29/2003 | EP1278766A2 Polynucleotides for diagnosing mammary gland cancer |
| 01/29/2003 | EP1278762A2 Nucleic acid construct system and method utilizing same useful for identifying protein-protein interactions |
| 01/29/2003 | EP1278761A2 MODULATION OF OLIGONUCLEOTIDE CpG-MEDIATED IMMUNE STIMULATION BY POSITIONAL MODIFICATION OF NUCLEOSIDES |
| 01/29/2003 | EP1278760A1 Tag library compounds, compositions, kits and methods of use |
| 01/29/2003 | EP1278584A1 Mipc column cleaning system and process |
| 01/29/2003 | EP1278544A2 Albumin fusion proteins |
| 01/29/2003 | EP1278542A2 Molecular antigen arrays and vaccines |